Arterial pathologies, including aortic aneurysms, can be treated by open surgical reconstruction, or alternatively, endovascular repair, which is a minimally invasive alternative to open surgical repair. Optimizing a successful outcome of endovascular repair, however, requires assessment of the patient's anatomy and, in the case of an arterial, or, more specifically, an aortic aneurysm, an appropriate stent spanning the proximal and distal ends of the aneurysm ensures essentially complete exclusion of the aneurysm sac by anchoring of the stent graft in the aorta to minimize endoleaks. Endoleaks and post-surgical enlargement of the aneurysm site often require additional repair to seal any expansion of the aneurysm sac and, generally, must be done without significantly compromising blood flow through the surgical site to surrounding viscera and associated structures.
Therefore, a need exists for new and improved endovascular repair devices and methods to treat arterial pathologies, such as aortic aneurysms.
The present invention relates to stent grafts for use in treating and repairing aortic and other arterial vascular damage, such as vascular damage associated with aortic aneurysms, including aortic aneurysms in regions of the aorta having arterial branches that supply blood to vital organs and tissues, such as thoracic aortic aneurysms, abdominal aortic aneurysms, thoracoabdominal aortic aneurysms, juxtarenal aortic aneurysms and short-neck abdominal aortic aneurysms.
In one embodiment, the invention is a stent graft that includes a luminal graft component having a proximal open end and a distal open end. A plurality of stents are distributed longitudinally along the luminal graft component, and at least one of the stents has struts that are joined to define proximal and distal apices. At least one ligature traverses at least a portion of the struts of at least one of the stents. The ligature includes ends that, when linked, at least partially radially constrict each corresponding stent. A pair of anchor loops at the luminal graft component longitudinally span the ends of each associated ligature when linked to radially constrict the corresponding stent.
In another embodiment, the invention is a stent graft delivery system that includes a stent graft. The stent graft includes a luminal graft component having a proximal open end and a distal open end, and defines a lumen. A plurality of stents are distributed longitudinally along the luminal graft component, and at least one of the stents has struts that are joined to define proximal and distal apices. At least one ligature traverses at least a portion of the struts. The ligature includes ends that, when linked, at least partially radially constrict the stent. A pair of anchor loops at the luminal graft component longitudinally span the ends of each associated ligature when linked to radially constrict the corresponding stent. A wire extends longitudinally along the luminal graft component, and through the anchor loops, linking the ligature ends and thereby radially constricting at least a portion of the stents of the stent graft, whereby retraction of the wire from the ends of the at least one ligature releases the ends of stent graft from constriction by the at least one ligature.
In still another embodiment, the invention is a method of implanting a stent graft at an arterial aneurysm of a subject. The method includes advancing a stent graft to an arterial aneurysm of the subject, wherein the stent graft includes at least one ligature extending about a periphery of the stent graft, the ligature traversing struts of a radial stent of the stent graft and having ends that are linked by a wire extending parallel to a longitudinal axis of the stent graft and through anchor loops longitudinally spanning the linked ends to thereby maintain the stent graft in a radially constricted position. The wire is retracted from the at least one ligature and the anchor loops, consequently releasing the ends of the ligature from each other, whereby the stent graft radially expands from the radially constricted position to a radially expanded position, thereby implanting the stent graft at the arterial aneurysm of the subject.
This invention has many advantages. For example, the physician can rotate or reposition the stent graft after it has been partially deployed to align a fenestration in the stent graft with a branch vessel, such as by only partially retracting the wire radially constricting stents of the stent graft, thereby providing greater control over delivery systems that are only able to position the stent graft before deployment begins. As a consequence, a stent graft can be deployed at a surgical site with more accuracy, less risk of injury to the vasculature of the subject, and without significant risk of distorting the intended shape of the stent graft when implanted at the surgical site.
The foregoing will be apparent from the following more particular description of example embodiments, as illustrated in the accompanying drawings in which like reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating embodiments. The same number present in different figures represents the same item.
A description of example embodiments follows.
The invention is generally directed to a stent graft and a delivery system that includes a stent graft and a plurality of wires extending through the lumen of the stent graft and on each lateral side of a fenestration in the stent graft. The invention also is directed to a method of use of the stent graft and delivery system of the invention. The stent graft delivery system and method of its us treat aortic vascular damage, such as vascular damage associated with an aortic aneurysms, including in regions of the aorta having arterial branches that supply blood to vital organs and tissues, such as thoracic aortic aneurysms, abdominal aortic aneurysms, thoracoabdominal aortic aneurysms, including juxtarenal aortic aneurysms and short-neck abdominal aortic aneurysms.
When reference is made herein to a prosthesis, also referred to herein as “stent graft,” “stent graft,” or “vascular prosthesis,” to be delivered, or implanted in a patient, the word “proximal” means that portion of the prosthesis or component of the prosthesis that is relatively close to the heart of the patient and “distal” means that portion of the prosthesis or component of the prosthesis that is relatively far from the heart of the patient.
When, however, reference is made to a delivery system or a component of a delivery system employed to deliver, or implant, a prosthesis, the word, “proximal,” as employed herein, means closer to the clinician using the delivery system. When reference is made to a delivery system or a component of a delivery system, “distal,” as that term is employed herein, means, further away from the clinician using the delivery system.
For clarity, the word “proximate” means “close to,” as opposed to the meanings ascribed to “proximal” or “distal” described above with respect to either the prosthesis or a delivery system.
One embodiment of a stent graft delivery system of the invention is shown in
Stents 28 of stent graft 12 are distributed radially about luminal graft component 14 and longitudinally along luminal graft component 14. Stents 28 include struts 30 that are joined at either end to defined proximal apices 32 and distal apices 34. Stents 28 are fabricated of a suitable material, such as is known in the art. In one embodiment, stents 28 are fabricated of a material that causes stents to radially self-expand upon release from radial constraint. Examples of suitable materials of radial self-expanding stents include a shape memory alloy, such as Nitinol. Examples of stents not formed of a shape memory alloy include those formed of stainless steel. In embodiments of the invention that do not employ a shape memory alloy, or are otherwise not radially self-expanding, a balloon catheter, for example, can be employed to radially expand stents that have been released from radial constriction, as is known in the art. Stents 28 can also include a radiopaque component, as is known in the art, such as at least one radiopacifier selected from the group consisting of barium sulfate, bismuth, tungsten, platinum-iridium and tantalum-tungsten.
Ligatures 36 extend about luminal graft component 14 and include ends 38,40. Ligatures 36 are formed of a suitable material, such as is known in the art. Examples of suitable materials of ligatures 36 include polyester, and nylon. As shown in
Returning to
In another embodiment, circular ligatures 160 extend about the periphery of stent graft 12 to form distally opposed ends 162,164 of circular ligatures 160 that are linked by wire 46. Wire 46 is stabilized by anchor loops 50,52 at the stent graft as shown in
As shown in
Following direction of stent graft to a position that spans aneurysm 152, and at least partial rotational and axial alignment of stent graft at aneurysm 152, wire 122 is partially retracted from loops 150 of ligatures and from anchor loops 153. Proximal retraction of wire handle 128 toward proximal handle 118, in the direction indicated by arrow 160, as can be seen in
Vascular prostheses implanted by the stent graft systems and methods of the invention can be implanted, for example, by transfemoral access. Additional branch prostheses that are directed into the vascular prostheses of the invention can be implanted, for example, by supraaortic vessel access (e.g., through the brachial artery), or by transfemoral access, or access from some other branch or branches of major blood vessels, including peripheral blood vessels.
The teachings of all patents, published applications and references cited herein are incorporated by reference in their entirety. The relevant teachings of all patents, published applications and references cited herein are incorporated by reference in their entirety. The relevant teachings of U.S. Pat. Nos. 8,292,943; 7,763,063; 8,308,790; 8,070,790; 8,740,963; 8,007,605; 9,320,631; 8,062,349; 9,198,786; 8,062,345; 9,561,124; 9,173,755; 8,449,595; 8,636,788; 9,333,104; 9,408,734; 9,408,735; 8,500,792; 9,220,617; 9,364,314; 9,101,506; 8,998,970; 9,554,929; 9,439,751; 9,592,112; 9,655,712, 9,827,123, 9,877,857, 9,907,686; U.S. patent application Ser. Nos. 14/575,673; 15/166,818; 15/167,055; 14/272,818; 14/861,479; 15/478,424; 15/478,737; 15/587,664; 15/604,032; 15/672,404; 15/816,772; 15/839,272; 15/417,467; PCT/US2017/025844; PCT/US2017/025849; PCT/US2017/025912; PCT/US2017/034223 and PCT/US2017/046062, are also incorporated by reference in their entirety.
The relevant teachings of International Application Numbers: PCT/US2018/019355; PCT/US2018/019344; PCT/US2018/019349; PCT/US2018/019353; PCT/US2018/019354; PCT/US2018/019352; PCT/US2018/019350; PCT/US2018/019356; PCT/US2018/019351; PCT/US2018/019510, are also incorporated by reference in their entirety.
While example embodiments have been particularly shown and described, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the embodiments encompassed by the appended claims.
This application is a continuation of International Application No. PCT/US2018/019342, which designated the United States and was filed on Feb. 23, 2018, published in English, which claims the benefit of U.S. Provisional Application No. 62/463,057, filed Feb. 24, 2017. The entire teachings of the above applications are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
5123917 | Lee | Jun 1992 | A |
5507769 | Marin et al. | Apr 1996 | A |
5755769 | Richard et al. | May 1998 | A |
5873906 | Lau | Feb 1999 | A |
6113623 | Sgro | Sep 2000 | A |
6171334 | Cox | Jan 2001 | B1 |
6280464 | Hayashi | Aug 2001 | B1 |
6395018 | Castaneda | May 2002 | B1 |
7435253 | Hartley et al. | Oct 2008 | B1 |
7637940 | Kocur et al. | Dec 2009 | B2 |
7763063 | Arbefeuille et al. | Jul 2010 | B2 |
8007605 | Arbefeuille et al. | Aug 2011 | B2 |
8062345 | Ouellette et al. | Nov 2011 | B2 |
8172895 | Anderson et al. | May 2012 | B2 |
8236040 | Mayberry et al. | Aug 2012 | B2 |
8480725 | Rasmussen et al. | Jul 2013 | B2 |
8486129 | Lautherjung | Jul 2013 | B2 |
8500792 | Berra | Aug 2013 | B2 |
8641752 | Holm et al. | Feb 2014 | B1 |
8808351 | Osborne | Aug 2014 | B2 |
8926693 | Duffy et al. | Jan 2015 | B2 |
9101455 | Roeder et al. | Aug 2015 | B2 |
9101506 | Arbefeuille et al. | Aug 2015 | B2 |
9259336 | Schaeffer et al. | Feb 2016 | B2 |
9364314 | Berra et al. | Jun 2016 | B2 |
9375308 | Norris | Jun 2016 | B2 |
9439751 | White et al. | Sep 2016 | B2 |
9592112 | Arbefeuille et al. | Mar 2017 | B2 |
9827123 | Arbefeuille et al. | Nov 2017 | B2 |
9861503 | Barthold et al. | Jan 2018 | B2 |
9877857 | Arbefeuille et al. | Jan 2018 | B2 |
10005269 | Hall et al. | Jun 2018 | B2 |
10080674 | Yuan et al. | Sep 2018 | B2 |
10299951 | Arbefeuille et al. | May 2019 | B2 |
10390930 | Arbefeuille et al. | Aug 2019 | B2 |
10617542 | Chakfe et al. | Apr 2020 | B2 |
10675850 | Hall et al. | Jun 2020 | B2 |
10898357 | Arbefeuille et al. | Jan 2021 | B2 |
11219540 | Arbefeuille | Jan 2022 | B2 |
11291572 | Garcia | Apr 2022 | B2 |
20020062133 | Gilson et al. | May 2002 | A1 |
20020177890 | Lenker | Nov 2002 | A1 |
20020188344 | Bolea et al. | Dec 2002 | A1 |
20020193872 | Trout et al. | Dec 2002 | A1 |
20040073289 | Hartley | Apr 2004 | A1 |
20050119722 | Styrc et al. | Jun 2005 | A1 |
20050131517 | Hartley et al. | Jun 2005 | A1 |
20050131518 | Hartley et al. | Jun 2005 | A1 |
20050131519 | Hartley | Jun 2005 | A1 |
20050131523 | Bashiri et al. | Jun 2005 | A1 |
20060015171 | Armstrong | Jan 2006 | A1 |
20060020319 | Kim et al. | Jan 2006 | A1 |
20060184226 | Austin | Aug 2006 | A1 |
20070055360 | Hanson et al. | Mar 2007 | A1 |
20070135904 | Eidenschink et al. | Jun 2007 | A1 |
20070213805 | Schaeffer | Sep 2007 | A1 |
20070233223 | Styrc | Oct 2007 | A1 |
20080091260 | Pomeranz et al. | Apr 2008 | A1 |
20080269867 | Johnson | Oct 2008 | A1 |
20100004730 | Benjamin et al. | Jan 2010 | A1 |
20100121429 | Greenan et al. | May 2010 | A1 |
20100234932 | Arbefeuille et al. | Sep 2010 | A1 |
20100316830 | Hartley et al. | Dec 2010 | A1 |
20110190862 | Bashiri et al. | Aug 2011 | A1 |
20110257720 | Peterson et al. | Oct 2011 | A1 |
20120221096 | Roeder et al. | Aug 2012 | A1 |
20120271401 | Bruszewski et al. | Oct 2012 | A1 |
20130116773 | Roeder et al. | May 2013 | A1 |
20130116775 | Roeder et al. | May 2013 | A1 |
20130123900 | Eblacas et al. | May 2013 | A1 |
20130158648 | Hartley et al. | Jun 2013 | A1 |
20130184806 | Arbefeuille et al. | Jul 2013 | A1 |
20130245742 | Norris | Sep 2013 | A1 |
20130282102 | Peterson | Oct 2013 | A1 |
20130289713 | Pearson et al. | Oct 2013 | A1 |
20140039597 | Arbefeuille et al. | Feb 2014 | A9 |
20140046428 | Cragg et al. | Feb 2014 | A1 |
20140324150 | Stephens et al. | Oct 2014 | A1 |
20150105819 | Becking et al. | Apr 2015 | A1 |
20150105849 | Cohen et al. | Apr 2015 | A1 |
20150202065 | Shalev et al. | Jul 2015 | A1 |
20150202067 | Barrand et al. | Jul 2015 | A1 |
20150272755 | Arbefeuille et al. | Oct 2015 | A1 |
20150335452 | Rao et al. | Nov 2015 | A1 |
20160184078 | Choubey et al. | Jun 2016 | A1 |
20160199207 | Treacy et al. | Jul 2016 | A1 |
20160302950 | Marmur et al. | Oct 2016 | A1 |
20170135807 | Arbefeuille et al. | May 2017 | A1 |
20170281382 | Lostetter et al. | Oct 2017 | A1 |
20180071123 | Arbefeuille et al. | Mar 2018 | A1 |
20180296374 | Chakfe et al. | Oct 2018 | A1 |
20190231571 | Lostetter | Aug 2019 | A1 |
20190247178 | Arbefeuille | Aug 2019 | A1 |
20190247179 | Lostetter | Aug 2019 | A1 |
20190247213 | Lostetter | Aug 2019 | A1 |
20190269497 | Arbefeuille | Sep 2019 | A1 |
20190269498 | Arbefeuille et al. | Sep 2019 | A1 |
20190282355 | Lostetter | Sep 2019 | A1 |
20190350694 | Arbefeuille et al. | Nov 2019 | A1 |
20210100669 | Arbefeuille et al. | Apr 2021 | A1 |
Number | Date | Country |
---|---|---|
105832447 | Aug 2016 | CN |
1847234 | Oct 2007 | EP |
1847236 | Oct 2007 | EP |
2471498 | Jul 2012 | EP |
2517672 | Oct 2012 | EP |
2735283 | May 2014 | EP |
2740440 | Jun 2014 | EP |
2745812 | Jun 2014 | EP |
2745813 | Jun 2014 | EP |
2749250 | Jul 2014 | EP |
2749251 | Jul 2014 | EP |
3040054 | Jul 2016 | EP |
3068339 | Sep 2016 | EP |
3078349 | Oct 2016 | EP |
3272319 | Jan 2018 | EP |
WO-9703624 | Feb 1997 | WO |
WO-9929262 | Jun 1999 | WO |
WO-9934749 | Jul 1999 | WO |
WO-0160285 | Aug 2001 | WO |
WO-02083038 | Oct 2002 | WO |
WO-2005034809 | Apr 2005 | WO |
WO-2006037086 | Apr 2006 | WO |
WO-2008130503 | Oct 2008 | WO |
WO-2009009376 | Jan 2009 | WO |
WO-2009126906 | Oct 2009 | WO |
WO-2009148594 | Dec 2009 | WO |
WO-2010024880 | Mar 2010 | WO |
WO-2010030370 | Mar 2010 | WO |
WO-2010127040 | Nov 2010 | WO |
WO-2012116368 | Aug 2012 | WO |
WO-2012145823 | Nov 2012 | WO |
WO-2015070792 | May 2015 | WO |
WO-2016122862 | Aug 2016 | WO |
WO-2017218474 | Dec 2017 | WO |
WO-2018026768 | Feb 2018 | WO |
Entry |
---|
International Preliminary Report on Patentability for International Application No. PCT/US2018/019342 dated Aug. 27, 2019. |
International Search Report and Written Opinion for International Application No. PCT/US2018/019342 dated May 22, 2018. |
Number | Date | Country | |
---|---|---|---|
20190269498 A1 | Sep 2019 | US |
Number | Date | Country | |
---|---|---|---|
62463057 | Feb 2017 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/US2018/019342 | Feb 2018 | US |
Child | 16414292 | US |